Lindbrook Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Lindbrook Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-26	Closed	-$4K	–	2076
2021 Q2	$4K	Hold	26	–	–	﹤0.01%	1427
2021 Q1	$4K	Buy	26 +15	+136%	+$2.04K	﹤0.01%	1378
2020 Q4	$1K	Hold	11	–	–	﹤0.01%	1749
2020 Q3	$1K	Hold	11	–	–	﹤0.01%	1716
2020 Q2	$1K	Hold	11	–	–	﹤0.01%	1688
2020 Q1	$1K	Buy	+11	New	+$1.07K	﹤0.01%	1646
2019 Q3	–	Sell	-12	Closed	-$1K	–	1575
2019 Q2	$1K	Hold	12	–	–	﹤0.01%	1380
2019 Q1	$1K	Hold	12	–	–	﹤0.01%	1367
2018 Q4	$1K	Buy	+12	New	+$1.21K	﹤0.01%	1323

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Lindbrook Capital's PRAH Position: Q3 2021 in Review

Lindbrook Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 26 shares — an estimated $4K sold.

Lindbrook Capital first reported a position in PRAH in Q4 2018 and held it in 9 quarters. The position peaked at $4K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Lindbrook Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Lindbrook Capital sold 26 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $4K.
Lindbrook Capital first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 9 quarters.
Lindbrook Capital's PRA Health Sciences, Inc. position peaked at $4K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.